Pharmaceutical Firms
-
{
- All
- News
- Videos
-
Health Ministry Mulls Ban On Cough Syrups For Children Under 2 Years: Report
New Delhi, April 11 (IANS) Health Ministry is reportedly considering banning prescriptions of paediatric cough syrups for children under two years and discouraging their use for those under five.
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory
India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates drug laws and could attract regulatory action.
-
'National Image Dented': Top Court Slams Pharma Firm Over Cough Syrup Deaths In Uzbekistan
"Do you realise what dent it has caused to the country's image?" the Supreme Court on Thursday asked a pharmaceutical firm whose cough syrups allegedly resulted in the death of more than 18 children in Uzbekistan.
-
"Kindly Relieve Me ASAP": Pharma Firm Finance Boss Quits Over Delhi Pollution
This resignation is seen as an unusual event in Indian corporate history, where an executive has cited environmental conditions as the reason for leaving.
-
Cough Syrup Smuggling: Case Filed Against 12 More Pharmaceutical Firms In UP
The food and drugs department of the Uttar Pradesh government filed a case on Friday against 12 more pharmaceutical firms in connection with the codeine-containing cough syrup-smuggling case in Varanasi.
-
Probe Agency ED Raids Premises Linked To Firm Behind 'Killer' Cough Syrup
The 'Coldrif' cough syrup was found to be "dangerously" adulterated with diethylene glycol (DEG), a highly poisonous substance.
-
Operation Midnight: How Owner Of Pharma Firm Behind Syrup Tragedy Was Arrested
The pharmaceutical company owner, the key accused in the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh, was arrested by the state police after a dramatic midnight operation.
-
Pharma Firm Owner Arrested Over 20 Children's Deaths Linked To Coldrif Syrup
The owner of the Tamil Nadu-based pharmaceuticals company that manufactured the adulterated Coldrif cough syrup linked to dozens of children's deaths in several states has been detained.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
Mumbai-Born CEO Joins Fortune 100 List With Satya Nadella, Sundar Pichai
Indian-origin CEO Reshma Kewalramani has made it to the world's 100 Most Powerful People in Business
-
Trump Warns Pharma Companies To Cut Prices Or Be Punished
US President Donald Trump told major pharmaceutical firms Thursday to lower prices or face punishment, as he moved to give Americans relief from medicine costs much higher than elsewhere in the world.
-
Health Ministry Mulls Ban On Cough Syrups For Children Under 2 Years: Report
New Delhi, April 11 (IANS) Health Ministry is reportedly considering banning prescriptions of paediatric cough syrups for children under two years and discouraging their use for those under five.
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory
India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates drug laws and could attract regulatory action.
-
'National Image Dented': Top Court Slams Pharma Firm Over Cough Syrup Deaths In Uzbekistan
"Do you realise what dent it has caused to the country's image?" the Supreme Court on Thursday asked a pharmaceutical firm whose cough syrups allegedly resulted in the death of more than 18 children in Uzbekistan.
-
"Kindly Relieve Me ASAP": Pharma Firm Finance Boss Quits Over Delhi Pollution
This resignation is seen as an unusual event in Indian corporate history, where an executive has cited environmental conditions as the reason for leaving.
-
Cough Syrup Smuggling: Case Filed Against 12 More Pharmaceutical Firms In UP
The food and drugs department of the Uttar Pradesh government filed a case on Friday against 12 more pharmaceutical firms in connection with the codeine-containing cough syrup-smuggling case in Varanasi.
-
Probe Agency ED Raids Premises Linked To Firm Behind 'Killer' Cough Syrup
The 'Coldrif' cough syrup was found to be "dangerously" adulterated with diethylene glycol (DEG), a highly poisonous substance.
-
Operation Midnight: How Owner Of Pharma Firm Behind Syrup Tragedy Was Arrested
The pharmaceutical company owner, the key accused in the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh, was arrested by the state police after a dramatic midnight operation.
-
Pharma Firm Owner Arrested Over 20 Children's Deaths Linked To Coldrif Syrup
The owner of the Tamil Nadu-based pharmaceuticals company that manufactured the adulterated Coldrif cough syrup linked to dozens of children's deaths in several states has been detained.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
Mumbai-Born CEO Joins Fortune 100 List With Satya Nadella, Sundar Pichai
Indian-origin CEO Reshma Kewalramani has made it to the world's 100 Most Powerful People in Business
-
Trump Warns Pharma Companies To Cut Prices Or Be Punished
US President Donald Trump told major pharmaceutical firms Thursday to lower prices or face punishment, as he moved to give Americans relief from medicine costs much higher than elsewhere in the world.
